Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Elekta
AddedFeb 19, 2024
UpdatedJun 28, 2026
Elekta

Elekta

Public

Sweden-based Elekta AB develops advanced medical tools for neurology and cancer treatment, including the innovative Gamma Knife.

HQ
Stockholm, Stockholm County, SE
Founded
1972
Overview
Compare
Employees
Website

Founded in 1972 by Lars Leksell and Laurent Leksell, Elekta AB is a Swedish company headquartered in Stockholm that specializes in developing advanced medical tools for the treatment of neurological disorders and cancer. The company's core mission is to ensure that everyone has access to the best cancer care. Elekta's flagship products include the Gamma Knife, a non-invasive surgical tool for managing intracranial lesions, and a comprehensive system for stereotactic neurosurgery. The company operates globally, with over 40 offices worldwide, focusing on neuroscience, radiation therapy, radiosurgery, oncology, and electronic medical records.

Notable figures associated with Elekta include its founders, Lars and Laurent Leksell. The company is publicly traded on Nasdaq Stockholm under the ticker EKTA B. Elekta has achieved significant milestones, such as the widespread adoption of the Gamma Knife and the development of the Elekta Evo, a versatile CT-Linac system. These innovations have solidified Elekta's impact on improving cancer treatment and neurosurgery, making it a leader in medical technology and patient care.

Elekta - Quick Facts

When was Elekta founded?

Elekta was founded in 1972.

Where is Elekta's headquarters located?

Elekta's headquarters is located in Stockholm, Stockholm County, SE.

How many employees does Elekta have?

Elekta has 4,700 employees as of Feb 12, 2024.

Elekta - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Robotics
  • Software
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 4649Wholesale of other household goods
  • 7010Activities of head offices
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 550000Management of Companies and Enterprises
  • 551000Management of Companies and Enterprises
  • 551100Management of Companies and Enterprises
  • 551110Management of Companies and Enterprises
  • 551114Corporate, Subsidiary, and Regional Managing Offices
  • 330000Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies